ClinicalTrials.Veeva

Menu

Evaluation of the Sarcopenia in Hepatobiliary Surgery (SARFO)

U

University Hospital, Angers

Status

Terminated

Conditions

Postoperative Complications
Surgery
Hepatobiliary Disease
Sarcopenia

Study type

Observational

Funder types

Other

Identifiers

NCT03754452
2018-A1104-51

Details and patient eligibility

About

The sarcopenia is defined as a loss of muscle mass and a loss of muscle function ( strength or performance). Some studies showed that the sarcopenia increase the postoperative complications and the overall survival in abdominal surgery. But the sarcopenia is not evaluated in the Hepatobiliary surgery. This prospective, monconcentrique study aim to evaluate the prevalence of sarcopenia, and its associated morbimortality in hepatobiliary surgery for malignant or benign tumors.

Enrollment

45 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • hepatobiliary surgery
  • scheduled surgery
  • oral consent

Exclusion criteria

  • pregnancy
  • patient under low protection
  • emergency surgery
  • hepatic encephalopathy stage II, III and IV

Trial contacts and locations

1

Loading...

Central trial contact

Julien BARBIEUX, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems